Tyrosine Kinase
Receptor tyrosine kinases bind to extracellular ligands/growth factors, which promotes receptor dimerization and autophosphorylation of receptor tyrosine residues. This triggers a cascade of downstream events through phosphorylation of intracellular proteins that ultimately transduce the extracellular signal to the nucleus, causing changes in gene expression. Receptor tyrosine kinases include EGFR/ErbB, PDGFR, VEGFR, FGFR and MET subfamilies etc. Dysfunctions in tyrosine phosphorylation are linked to oncogenic transformation. In additions, various adaptor and effector proteins couple to carboxy-terminal of an active kinase. For instance, binding of the GRB2 adaptor protein activates EGFR and MAPK/ERK signaling.
Non-receptor tyrosine kinases involve many well-defined proteins (e.g. the Src family kinases, c-Abl, and Jak kinases) and other kinases which regulates cell growth and differentiation. For example, Src family kinases are curial for activating and inhibitory pathways in the innate immune response.
- A8232 Nilotinib(AMN-107)1 CitationTarget: Bcr-AblSummary: Bcr-Abl kinase inhibitor,selective
- A2149 Bosutinib (SKI-606)1 CitationTarget: Bcr-Abl|SrcSummary: Potent Abl/Src kinases
- A1805 Imatinib Mesylate (STI571)Target: PDGFR|c-Kit|Bcr-AblSummary: Abl/c-kit/PDGFR inhibitor
- A2412 CP-724714Target: VEGFR|PDGFR|Bcr-Abl|Src|EGFR|c-MET|Insulin Receptors|IRG-1RSummary: HER2 inhibitor,potent and selective
- A5467 Ponatinib (AP24534)1 CitationTarget: VEGFR|PDGFR|Bcr-Abl|FGFR|SrcSummary: pan-BCR-ABL inhibitor,multi-kinase inhibitor
- A8604 GNF 5Target: Bcr-AblSummary: Bcr-Abl inhibitor
- B1402 GZD824Target: Bcr-AblSummary: Bcr-Abl inhibitor,novel orally bioavailable
- B1404 DCC-2036 (Rebastinib)Target: FLT3|Bcr-Abl|Tie-2|KDRSummary: Bcr-Abl inhibitor
- B2171 Imatinib (STI571)Target: PDGFR|c-Kit|Bcr-AblSummary: Protein-tyrosine kinase inhibitor
- A4123 KW 2449Target: Aurora Kinases|FLT3|Bcr-AblSummary: Multikinase inhibitor